KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:KEQU • US4928541048

40.13 USD
-0.64 (-1.57%)
Last: Feb 9, 2026, 08:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, KEQU scores 5 out of 10 in our fundamental rating. KEQU was compared to 186 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year KEQU was profitable.
  • KEQU had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 6.21%, KEQU belongs to the best of the industry, outperforming 86.02% of the companies in the same industry.
  • The Return On Equity of KEQU (16.81%) is better than 92.47% of its industry peers.
  • With an excellent Return On Invested Capital value of 10.67%, KEQU belongs to the best of the industry, outperforming 90.86% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.79%.
  • The last Return On Invested Capital (10.67%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROIC 10.67%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • KEQU has a better Profit Margin (4.11%) than 76.34% of its industry peers.
  • KEQU's Operating Margin of 6.89% is fine compared to the rest of the industry. KEQU outperforms 72.58% of its industry peers.
  • With a Gross Margin value of 29.09%, KEQU is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
  • The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
  • KEQU has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for KEQU is higher compared to a year ago.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 3.35 indicates that KEQU is not in any danger for bankruptcy at the moment.
  • KEQU has a better Altman-Z score (3.35) than 71.51% of its industry peers.
  • The Debt to FCF ratio of KEQU is 12.32, which is on the high side as it means it would take KEQU, 12.32 years of fcf income to pay off all of its debts.
  • KEQU has a better Debt to FCF ratio (12.32) than 72.04% of its industry peers.
  • A Debt/Equity ratio of 0.85 indicates that KEQU is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.85, KEQU is doing worse than 73.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Altman-Z 3.35
ROIC/WACC1.09
WACC9.79%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • KEQU has a Current Ratio of 2.48. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
  • KEQU has a Current ratio (2.48) which is in line with its industry peers.
  • KEQU has a Quick Ratio of 1.71. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of KEQU (1.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.71
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.55%.
  • KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.02%.
  • The Revenue has been growing by 10.27% on average over the past years. This is quite good.
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.95, the valuation of KEQU can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.31% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.06. KEQU is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.95
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.31% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, KEQU is valued cheaper than 87.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.49
EV/EBITDA 6.42
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (2/9/2026, 8:11:46 PM)

40.13

-0.64 (-1.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-10
Earnings (Next)03-10
Inst Owners41.13%
Inst Owner Change1.23%
Ins Owners15.89%
Ins Owner Change-3.83%
Market Cap115.17M
Revenue(TTM)285.51M
Net Income(TTM)11.74M
Analysts82.86
Price TargetN/A
Short Float %1.25%
Short Ratio3.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.95
Fwd PE N/A
P/S 0.4
P/FCF 22.49
P/OCF 13.29
P/B 1.65
P/tB 2.86
EV/EBITDA 6.42
EPS(TTM)5.05
EY12.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.78
FCFY4.45%
OCF(TTM)3.02
OCFY7.53%
SpS99.48
BVpS24.34
TBVpS14.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number52.59
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 16.81%
ROCE 13.73%
ROIC 10.67%
ROICexc 11.69%
ROICexgc 15.07%
OM 6.89%
PM (TTM) 4.11%
GM 29.09%
FCFM 1.79%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.51
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 12.32
Debt/EBITDA 2.29
Cap/Depr 56.58%
Cap/Sales 1.24%
Interest Coverage 250
Cash Conversion 33.42%
Profit Quality 43.61%
Current Ratio 2.48
Quick Ratio 1.71
Altman-Z 3.35
F-Score4
WACC9.79%
ROIC/WACC1.09
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.02%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1290.93%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y51.55%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


How financially healthy is KEWAUNEE SCIENTIFIC CP?

The financial health rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 5 / 10.


Is the dividend of KEWAUNEE SCIENTIFIC CP sustainable?

The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.